Literature DB >> 15269075

Should recombinant human growth hormone therapy be used in short small for gestational age children?

L B Johnston1, M O Savage.   

Abstract

Short small for gestational age (SGA) children represent 20% of all children with short stature and therefore constitute a significant portion of the caseload in a growth clinic. The recent approval of recombinant human growth hormone (GH) for the treatment of short stature in SGA children by the European Union's Committee on Proprietary Medicinal Products offers a new licensed therapeutic option. This article examines the role of GH therapy in short SGA children with particular reference to selection of patients, effectiveness, safety, and its potential metabolic implications.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15269075      PMCID： PMC1720030          DOI： 10.1136/adc.2003.034785

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  41 in total

1.  Effect of discontinuation of growth hormone treatment on risk factors for cardiovascular disease in adolescents born small for gestational age.

Authors:  Yvonne van Pareren; Paul Mulder; Mieke Houdijk; Maarten Jansen; Maarten Reeser; Anita Hokken-Koelega
Journal:  J Clin Endocrinol Metab       Date:  2003-01       Impact factor: 5.958

2.  Improvement in adult height after growth hormone treatment in adolescents with short stature born small for gestational age: results of a randomized controlled study.

Authors:  Jean-Claude Carel; Pierre Chatelain; Pierre Rochiccioli; Jean-Louis Chaussain
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

3.  Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational-age infants at age 1 year: results from a prospective cohort.

Authors:  Néstor Soto; Rodrigo A Bazaes; Verónica Peña; Teresa Salazar; Alejandra Avila; Germán Iñiguez; Ken K Ong; David B Dunger; M Verónica Mericq
Journal:  J Clin Endocrinol Metab       Date:  2003-08       Impact factor: 5.958

4.  Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.

Authors:  Yvonne Van Pareren; Paul Mulder; Mieke Houdijk; Maarten Jansen; Maarten Reeser; Anita Hokken-Koelega
Journal:  J Clin Endocrinol Metab       Date:  2003-08       Impact factor: 5.958

Review 5.  International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001.

Authors:  Peter A Lee; Steven D Chernausek; Anita C S Hokken-Koelega; Paul Czernichow
Journal:  Pediatrics       Date:  2003-06       Impact factor: 7.124

6.  Blood glucose concentrations are reduced in children born small for gestational age (SGA), and thyroid-stimulating hormone levels are increased in SGA with blunted postnatal catch-up growth.

Authors:  Stefano Cianfarani; Arianna Maiorana; Caterina Geremia; Giuseppe Scirè; Gian Luigi Spadoni; Daniela Germani
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

7.  Learning, cognitive, and attentional problems in adolescents born small for gestational age.

Authors:  Michael J O'Keeffe; Michael O'Callaghan; Gail M Williams; Jake M Najman; William Bor
Journal:  Pediatrics       Date:  2003-08       Impact factor: 7.124

8.  Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database).

Authors:  Michael B Ranke; Anders Lindberg; Christopher T Cowell; Kerstin Albertsson Wikland; Edward O Reiter; Patrick Wilton; David A Price
Journal:  J Clin Endocrinol Metab       Date:  2003-01       Impact factor: 5.958

9.  Functional hypersomatotropism in small for gestational age (SGA) newborn infants.

Authors:  M Deiber; P Chatelain; D Naville; G Putet; B Salle
Journal:  J Clin Endocrinol Metab       Date:  1989-01       Impact factor: 5.958

10.  Physiological growth hormone secretion in children with short stature and intra-uterine growth retardation.

Authors:  F M Ackland; R Stanhope; C Eyre; G Hamill; J Jones; M A Preece
Journal:  Horm Res       Date:  1988
View more
  2 in total

1.  Identification of newborns with Fetal Growth Restriction (FGR) in weight and/or length based on constitutional growth potential.

Authors:  Nicole Mamelle; Magali Boniol; Olivier Rivière; Marie O Joly; Georges Mellier; Bernard Maria; Bernard Rousset; Olivier Claris
Journal:  Eur J Pediatr       Date:  2006-07-12       Impact factor: 3.183

2.  Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.

Authors:  Adnan Al Shaikh; Hadeer Daftardar; Abdul Aziz Alghamdi; Majd Jamjoom; Saniah Awidah; Mohamed E Ahmed; Ashraf T Soliman
Journal:  Acta Biomed       Date:  2020-03-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.